|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Vir Biotechnology, Inc. (VIR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
127,390,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. Co.'s existing pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus, influenza A virus, and human immunodeficiency virus. Co. has collaborate with Glaxo Wellcome UK Limited and GlaxoSmithKline Biologicals S.A. to focus on treating and preventing severe acute respiratory syndrome coronavirus 2 (the virus that causes COVID-19 illness). Co. is developing differentiated monoclonal antibodies, like sotrovimab and VIR-7832, as well as vaccines and small molecules.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
10,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$246,341 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
4 |
Total Shares Sold |
167,399 |
167,399 |
965,615 |
6,005,613 |
Total Sell Value |
$1,671,921 |
$1,671,921 |
$22,530,609 |
$153,953,368 |
Total People Sold |
5 |
5 |
9 |
11 |
Total Sell Transactions |
10 |
10 |
26 |
123 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-06-28 |
4 |
AS |
$25.10 |
$175,922 |
I/I |
(7,010) |
16,774,683 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-06-20 |
4 |
AS |
$25.18 |
$249,302 |
I/I |
(9,902) |
16,781,693 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-06-14 |
4 |
AS |
$25.92 |
$1,495,618 |
I/I |
(57,248) |
16,974,921 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-06-13 |
4 |
AS |
$26.81 |
$2,894,180 |
I/I |
(106,854) |
17,032,169 |
|
- |
|
Pang Phillip |
Chief Medical Officer |
|
2023-06-07 |
4 |
AS |
$25.95 |
$129,727 |
D/D |
(5,000) |
188,000 |
|
- |
|
Pang Phillip |
Chief Medical Officer |
|
2023-06-07 |
4 |
OE |
$1.53 |
$7,650 |
D/D |
5,000 |
193,000 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-06-05 |
4 |
AS |
$27.32 |
$141,998 |
I/I |
(5,197) |
17,139,023 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-06-02 |
4 |
AS |
$27.32 |
$938,732 |
I/I |
(34,365) |
17,144,220 |
|
- |
|
Rice Steven J. |
Chief Administrative Officer |
|
2023-06-01 |
4 |
AS |
$25.67 |
$64,175 |
D/D |
(2,500) |
106,840 |
|
- |
|
Ramasastry Saira |
Director |
|
2023-06-01 |
4 |
AS |
$25.67 |
$89,845 |
D/D |
(3,500) |
10,619 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-05-24 |
4 |
AS |
$25.89 |
$2,729,599 |
I/I |
(104,384) |
17,178,585 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-05-23 |
4 |
AS |
$25.84 |
$4,533,230 |
I/I |
(170,067) |
17,282,969 |
|
- |
|
More Robert J |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
45,088 |
|
- |
|
Sharp Philip A |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
121,174 |
|
- |
|
Sato Vicki L |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
1,333,351 |
|
- |
|
Hatfield Jeffrey S. |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
15,806 |
|
- |
|
Ramasastry Saira |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
14,119 |
|
- |
|
Napolitano Janet |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
15,806 |
|
- |
|
Perez Robert J |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
15,806 |
|
- |
|
Nelsen Robert |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
576,148 |
|
- |
|
Sigal Charles Elliott |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
15,806 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-05-22 |
4 |
AS |
$25.72 |
$2,363,905 |
I/I |
(91,896) |
17,453,036 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-05-19 |
4 |
AS |
$25.38 |
$2,326,231 |
I/I |
(91,651) |
17,544,932 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-05-05 |
4 |
AS |
$25.10 |
$3,414 |
I/I |
(136) |
17,636,583 |
|
- |
|
Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
|
2023-05-04 |
4 |
AS |
$25.55 |
$2,921,160 |
I/I |
(114,332) |
17,636,719 |
|
- |
|
575 Records found
|
|
Page 2 of 23 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|